Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-01-23
1999-11-02
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548248, 548249, 562598, A01N 4376, C07D26108, C07D26118, C07C 5703
Patent
active
059771518
ABSTRACT:
A compound of the formula ##STR1## where R.sup.1 is the radical of the formula II or III ##STR2## is suitable for the production of a pharmaceutical for the treatment of inflammations, carcinomatous diseases, or autoimmune diseases. A compound of the formula IV ##STR3## is suitable for the production of specific antibodies against a compound of the formula I for the discovery of specific-binding proteins from cell extracts, serum, blood, or synovial fluids, for the purification of proteins, for the modification of microtiter plates, or for the preparation of chromatography material, in particular of affinity chromatography material, and for use in diagnostics.
REFERENCES:
patent: 4284786 (1981-08-01), Kammerer et al.
patent: 4965276 (1990-10-01), Bartlett et al.
patent: 5494911 (1996-02-01), Barlett et al.
patent: 5547970 (1996-08-01), Weithmann et al.
patent: 5744664 (1998-04-01), Brekner et al.
G. Panayotou, et al., "Riding the Evanescent Wave", Current Biology, vol. 3, No. 12, pp. 913-915, 1993.
Biacore 2000 "Surface Plasmon Resonance".
Kurtz et al., "Leflunomide: an active antiinflammatory and antiproliferative agent in models of dermatologic disease", Chemical Abstracts, vol. 123, No. 19, Nov. 6, 1995, p. 57.
Robertson et al., "Leflunomie: inhibition of A-antigen induced autoimmune uveitis in Lewis rats", Chemical Abstracts, vol. 122, No. 5, Jan. 30, 1995, pp. 68-69.
Thoss et al., "Immunomodulation of rat antigen-induced arthritis by leflunomide alone and in combination with cyclosporin", Chemical Abstracts, vol. 124, No. 19, May 6, 1996, p. 108.
Dias et al., "Measurment of the active leflunomide metaboite (A77 1726) by reverse-phase high-performance liquid chromatopography", Chemical Abstracts, vol. 122, No. 15, Apr. 10, 1995, p. 9.
Kirschbaum Bernd
Mullner Stefan
Schwab Wilfried
Hoechst Aktiengesellschaft
Richter Johann
LandOfFree
Isoxazole and crotonamide derivatives and their use as pharmaceu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoxazole and crotonamide derivatives and their use as pharmaceu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazole and crotonamide derivatives and their use as pharmaceu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2135999